Product
BBI608
Aliases
BB608, BBI-608, Napabucasin
11 clinical trials
11 indications
Indication
hematologic malignanciesIndication
GlioblastomaIndication
Hepatocellular CarcinomaIndication
Stomach CancerIndication
Esophageal CancerIndication
CancerIndication
Advanced MalignanciesIndication
Pancreatic CancerIndication
Advanced Gastrointestinal CancerIndication
Colorectal CancerIndication
Colorectal cancerClinical trial
A Phase Ib Clinical Study of BBI608 for Adult Patients With Advanced, Refractory Hematologic MalignanciesStatus: Completed, Estimated PCD: 2018-12-14
Clinical trial
A Phase Ib/II Clinical Study of BBI608 in Combination With Temozolomide for Adult Patients With Recurrent or Progressed GlioblastomaStatus: Completed, Estimated PCD: 2018-10-09
Clinical trial
A Phase Ib/II Clinical Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular CarcinomaStatus: Completed, Estimated PCD: 2019-07-01
Clinical trial
A Phase Ib/II Clinical Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced MalignanciesStatus: Completed, Estimated PCD: 2021-06-01
Clinical trial
A Phase III Clinical Trial of BBI608 Plus Weekly Paclitaxel vs. Placebo Plus Weekly Paclitaxel in Adult Patients With Advanced, Previously Treated Gastric and Gastro-Esophageal Junction AdenocarcinomaStatus: Completed, Estimated PCD: 2017-09-20
Clinical trial
A Phase I Clinical Study of BBI608 in Adult Patients With Advanced MalignanciesStatus: Completed, Estimated PCD: 2015-08-06
Clinical trial
A Phase Ib Clinical Study of BBI608 and BBI503 Administered in Combination to Adult Patients With Advanced Solid TumorsStatus: Completed, Estimated PCD: 2019-12-01
Clinical trial
A Phase Ib Clinical Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Metastatic Pancreatic AdenocarcinomaStatus: Completed, Estimated PCD: 2020-06-01
Clinical trial
A Phase Ib/II Clinical Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal CancerStatus: Completed, Estimated PCD: 2019-03-01
Clinical trial
A Phase II Clinical Study of BBI608 in Adult Patients With Advanced Colorectal CancerStatus: Completed, Estimated PCD: 2018-06-01
Clinical trial
A Phase III Randomized Study of BBI608 and Best Supportive Care Versus Placebo and Best Supportive Care in Patients With Pretreated Advanced Colorectal CarcinomaStatus: Completed, Estimated PCD: 2016-05-07